Exspot

Quick links to important sections

Medically reviewed

Rosario Oropesa

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Exspot

Quick Facts

Property Description
Active ingredient Permethrin
Form Spot-on solution, topical liquid
Pharmacological class Synthetic Pyrethroid, Insecticide, Acaricide
General purpose Killing and control of external parasites (fleas, ticks)
Origin Synthetic compound

What Type of Medicine is Exspot?

Exspot is a specialized, brand-name veterinary drug categorized as a topical ectoparasiticide solution, authorized for use exclusively on dogs. The product belongs to the pharmacological class of insecticides and acaricides because its primary function is the control of external arthropod parasites. The preparation is designed specifically as a concentrated liquid spot-on solution in single-dose applicators, enabling highly localized topical application onto the skin. This classification signifies a key difference from systemic treatments, as Exspot acts directly on the animal's surface.

Composition: Permethrin, a Unique Pyrethroid

The formulation utilizes the single active ingredient, Permethrin, which is typically found in a high concentration of 65% m/v in an organic solvent base. Permethrin is a synthetic compound that falls into the chemical class of pyrethroids, structurally derived from the natural pyrethrins. Its high efficacy in arthropod control is linked to its neurotoxic properties. This high-concentration Permethrin formula is a differentiating factor, offering sustained contact repellency and rapid knockdown effects. Importantly, due to the specific toxicity profile of Permethrin, this formulation is not for use in cats.

General Purpose and Key Action

The general purpose of Exspot is the killing and control of external parasites on the canine host, including common pests such as fleas and ticks. Its action involves the active substance rapidly disrupting the function of the arthropod nerve cells, which quickly leads to the paralysis and subsequent elimination of the pests. This neurotoxic effect provides a means for the dog owner to manage and prevent current infestations, contributing to the animal’s overall comfort and health.

Regulatory References

  1. Permethrin - StatPearls - NCBI Bookshelf - NIH

What side effects are possible with Exspot?

Possible Side Effects and Safety Information

The officially documented adverse effects for Exspot (Permethrin 65% spot-on solution) are structured primarily around the regulatory classification of Very Rare, meaning they are observed in less than 1 in 10,000 animals treated. These reactions typically involve the Skin and Subcutaneous Tissue Disorders and are localized to the site of application.

Adverse Reaction Classification

Classification Examples of Documented Effects
Very Rare Transient erythema (redness), pruritus (itching), or discomfort at the application site. Systemic signs like vomiting, diarrhea, lethargy, or decreased appetite.
Rare to Very Rare Neurological signs, including muscle tremor, twitching, or ataxia (unsteady movement). Behavioural changes such as agitation or hyperactivity.

These effects, if they occur, are officially noted as transient; local skin reactions usually resolve spontaneously within 24 hours, and cosmetic changes to the hair coat typically disappear within 48 hours.

Critical Safety Constraints

The most critical regulatory constraint is the product's extreme toxicity to cats. Due to the high concentration of permethrin, the product is strictly contraindicated for use in cats and can be fatal to the species. Furthermore, regulatory documents state that safety has not been established for use in puppies under 7 weeks old, dogs weighing less than 1.5 kg, or bitches during pregnancy and lactation.

Accidental ingestion of a high dose may result in transient salivation, vomiting, or diarrhea, or in more severe cases, neurological signs. The product is also officially noted as being toxic for aquatic organisms, limiting a treated animal's contact with surface water for 48 hours.

Overdose and Emergency Response

Overdose and When to Seek Help

Overdose or accidental oral uptake in the target species (dogs) may result in transient gastrointestinal signs, including vomiting, diarrhea, and hypersalivation. Documented neurological disorders in the dog include tremors, muscle twitching, incoordination (ataxia), and hyperexcitability, though these signs are generally reported as self-resolving. Severe localized effects, such as increased erythema (redness) at the application site, may also occur.

The regulatory profile highlights a severe, potentially fatal risk to cats. Due to their unique physiology, cats are unable to metabolize permethrin effectively, and accidental exposure to the concentrated solution can induce convulsions that could be fatal. The product is strictly contraindicated for use in cats.

Management of overdose is limited to symptomatic and supportive treatment, as no known specific antidote is available. Immediate medical advice must be sought if the veterinary product is accidentally swallowed by a human or if persistent skin or eye irritation occurs. Veterinary advice is required immediately if a cat is exposed, or if any neurological or systemic signs in the dog persist or worsen beyond the expected transient period. In the event of accidental cat exposure, washing the cat with shampoo or soap is mandated.

Therapeutic Uses of Exspot

What Exspot Treats: Main Uses and Benefits

The medication is commonly used across therapeutic domains where additional symptomatic support is needed to control external pests. The product is used across conditions presenting with systemic or localized discomfort associated with fleas, ticks, and flies. It is relevant in clinical settings that involve acute or disruptive symptom patterns associated with parasitic infestation in dogs.

This product is applied in addressing these symptom clusters that interfere with daily comfort. It is often used during phases when symptoms become more noticeable, and contributes to easing the overall symptom load. The medicine is considered relevant in conditions involving inflammatory or irritative processes, such as acute episodes of Flea Allergic Dermatitis (FAD), when symptoms create noticeable physiological strain. It may assist with maintaining functional stability related to the irritation caused by biting insects like sand flies and mosquitoes.


Quick Fact: Support for Symptom Clusters

Quick Fact: Support for Symptoms that Interfere with Daily Functioning

The primary therapeutic benefit provides support that helps ease the overall symptom burden associated with irritation and tension from external parasites, and contributes to improved comfort during periods of heightened symptoms.

Regulatory References

  1. UK Veterinary Medicines Directorate (VMD)

Eligibility and Restrictions for Use

The eligibility profile for Exspot is strictly defined by regulatory authorities based on species, age, and physiological status. The medicine is only allowed for use in dogs; it is absolutely contraindicated in cats because the active ingredient, permethrin, is fatally toxic to felines.

Contraindicated Populations

Use is prohibited in dogs with a known hypersensitivity to permethrin or any of the product's excipients. Regulatory documents also advise against use in dogs that are sick, convalescent, or have extensive skin lesions on the application site.

Age and Conditional Use

Regulatory labeling establishes strict minimum age requirements, stating the product must not be used on puppies under 2 weeks old. Safety has not been established for very low-weight dogs (e.g., under 2 kg). Use during pregnancy, lactation, or in breeding animals is also conditional. For these populations, the medicine should only be used after a formal benefit-risk assessment by a licensed veterinarian, as safety data is not established.

What should I know about interactions with other medicines?

Interactions with other medicines and products

The official interaction profile for this medicine is defined primarily by species-specific prohibitions and administrative restrictions, reflecting its topical route of administration and high concentration of Permethrin.


Interaction Scope

Property Description
Medicinal product categories with documented interactions Other topical ectoparasiticides, spot-on solutions, and insecticidal agents.
Specific interacting medicines (if explicitly listed) The general category of Permethrin products and other active agents in the ectoparasiticide class are restricted from concurrent use.
Mechanistic basis of interactions None documented for systemic interactions. Basis is confined to potential additive toxicity from concurrent topical application and species-specific metabolic toxicity (felines).

Interaction-Related Restrictions

Classification Description
Contraindicated Combination The feline species is formally contraindicated for exposure due to high-risk, potentially fatal neurotoxicity documented in regulatory sources (e.g., VMD, NIH).
Timing-based interaction rules Mandatory separation is required between treated dogs and cats for a specified period (e.g., 24–72 hours or until application site is dry) to prevent transfer.
Population-specific interaction notes Cautionary restrictions apply to use in debilitated, aged, pregnant, or nursing dogs due to potential heightened risk of adverse reactions or sensitivity.

Official Interaction Statements

  • The feline species is formally contraindicated for exposure, necessitating label instructions for mandatory separation of treated dogs from cats.
  • Co-administration with other topical ectoparasiticides or insecticidal preparations is prohibited as a label restriction to avoid potential additive toxicity or overdose.
  • Cautionary notes for use are included for debilitated, aged, pregnant, or nursing dogs due to a documented elevated risk profile.

The regulatory interaction profile contains no documented classical systemic pharmacokinetic (CYP-mediated) or pharmacodynamic drug–drug interactions for the target species (dogs). This absence confirms the official focus on safety-related administrative and species constraints.

Mechanism of Action

How Exspot Works

Exspot works by a rapid-acting, neurotoxic mechanism that specifically targets the nervous system of external arthropod parasites. Its action is defined by a highly specific disruption of ion channel function, leading directly to the parasite's physiological failure.


Targeted Disruption of Sodium Channels

The primary molecular interaction of Permethrin is a modulator of voltage-gated sodium channels ( Na^+ channels) in arthropod nerve membranes. The mechanism causes a sustained influx of sodium ions into the nerve cell by preventing the channel from closing (delayed inactivation). This rapid accumulation of positive charge initiates a state of massive neural over-activity, which defines the initial molecular phase of the cascade.


Acute Neurophysiological Cascade

The sustained neural hyperexcitation quickly overwhelms the parasite's motor control pathways, resulting in immediate and uncontrolled muscle spasms and tremors. This neurophysiological overload causes the characteristic knockdown effect (rapid paralysis), which is the direct, systemic consequence of the disruption.


Metabolic Constraint and Mechanistic Specificity

This final domain addresses the boundary conditions of the drug's mechanism, specifically the role of metabolism in regulating its systemic concentration in non-target species. The mechanism is constrained by a species-specific metabolic difference (lack of glucuronidation) in cats, which prevents the rapid detoxification of Permethrin.

Dosage and Administration Information

Exspot is a specialized veterinary medicine administered exclusively through the topical route as a spot-on solution. This application method ensures the Permethrin active substance remains external, distinguishing it from internal or systemic treatments. The product is provided in pre-measured 1 ml plastic pipettes, and the dosing regimen is determined by the dog's body weight.

For dogs weighing 15 kg or less, the dose is a single 1 ml pipette. For dogs over 15 kg, the regimen requires two 1 ml pipettes, totaling 2 ml for the required coverage.

The medicine is used on an intermittent and cyclic basis, with the standard re-treatment frequency set at approximately every four weeks to maintain protection. If reapplication is needed sooner, the minimum permitted interval between doses is seven days.

Proper administration requires parting the coat and squeezing the solution directly onto the skin in specific locations, such as between the shoulder blades and the base of the tail for larger animals. Critically, the product must not be applied to the hair. Furthermore, a key procedural condition states that the treated animal must not be allowed to enter water or swim for 12 hours after treatment to preserve the product's effectiveness. The product is explicitly restricted to use in dogs and puppies 2 weeks old or older.

Recent Clinical Evidence

Research evidence / Overview of Studies for Exspot

Evidence for Control of Fleas and Ticks

Research on the permethrin 65% spot-on formulation has been conducted primarily in controlled settings to understand the outcomes measured when animals were exposed to common external parasites like fleas and ticks. Studies were applied in research contexts involving fluctuating or unstable symptoms related to infestation. These are often Randomized Controlled Trials (RCTs) using laboratory challenge models, which help show what has been observed so far under specific, standardized conditions.

Focus on Flea and Tick Killing (Acaricidal/Insecticidal Activity)

Studies monitored the speed of parasite elimination, measuring live parasite counts shortly after application and re-infestation. Findings describe patterns observed in the studies where measurements of live flea and tick counts showed a rapid decline. Research explored the sustained duration of this effect, tracking parasite numbers typically up to 35 to 42 days post-treatment in controlled challenge settings. Findings describe group patterns related to measurements of parasite counts that remained low during the observed time intervals.

Focus on Repellency and Anti-Attachment

Beyond elimination, studies explored outcomes related to physical discomfort by measuring the product's role in the outcomes related to reduced contact. Specialized research evaluated the product's repellency and anti-feeding properties against ticks, sand flies, and mosquitoes. Research describes patterns where a lower rate of successful landing and attachment of these insects was measured on treated animals compared to untreated animals.

Durability of Effect and Follow-up Duration

The evidence base focuses heavily on intermediate duration follow-up periods when evaluating the duration of observed measurements. Studies monitored the duration of effect, with typical follow-up lasting up to three to six weeks in laboratory and some field settings. Measurements related to parasite populations were observed over these defined time intervals. However, long-term effects are not fully established, and follow-up durations were limited in many initial efficacy trials.

Key Evidence Gaps and Areas of Uncertainty

One primary limitation is that a significant portion of the most consistent data is derived from controlled laboratory challenge models. Findings describe group patterns but also highlight that studies conducted in controlled laboratory settings may not fully account for all real-world environmental and host variables. Comparative evidence for this specific 65% single-active formulation is limited when evaluating all currently available alternative products. Data for certain other breed groups, puppies, or dogs with specific comorbidities remain insufficient within the main efficacy trials.

Key Studies & References

  1. Efficacy of Two 65% Permethrin Spot-on Formulations Against Canine Infestations of Ctenocephalides felis and Rhipicephalus sanguineus
  2. Prevention of Sand Fly Attack by Topical Application of a Permethrin-Pyriproxyfen Combination on Dogs
  3. Evaluation of the efficacy of 65% permethrin spot-on against fleas (C. felis) and ticks (R. sanguineus)
  4. Summary of Product Characteristics - Bob Martin Flea and Tick Spot On Solution 744mg (UK VMD)

Frequently Asked Questions (FAQ)

Common questions about Exspot (FAQ)


Q: Does Exspot need to be taken every day, or less often?

According to the official product information, Exspot is designed for intermittent and cyclic use, not for daily application. The standard frequency stated for re-treatment is approximately every four weeks. If reapplication is needed sooner, official guidelines specify that the minimum time allowed between doses is seven days.


Q: Is Exspot available over the counter?

The dispensing status of Exspot varies depending on the country or regulatory authority. In many jurisdictions, it is generally categorized as a product requiring veterinary professional oversight or dispensing. This classification indicates it is not typically sold as a general over-the-counter product.


Q: How quickly should I expect Exspot to start working?

Studies and official information describe the active ingredient's mechanism as rapid-acting upon contact with the external parasites. Research results from controlled challenge trials demonstrated high efficacy against certain ticks and fleas within 48 hours of application.


Q: What is the main difference between Exspot and other similar medicines?

Official documents define Exspot as a topical ectoparasiticide solution that contains a single active substance: Permethrin in a high concentration of 65% m/v. This specific high-concentration permethrin formulation is a key characteristic noted in the product description, distinguishing it from products with different active ingredients or concentrations.


Q: Why do some people say Exspot made them feel tired?

Exspot is a veterinary product only approved for use in dogs. In the target species, a systemic sign like lethargy (tiredness) is officially listed as a very rare reported side effect. These effects, if they occur, are generally described as transient, meaning they resolve on their own after a short time.


Q: How long does the effect of a single use of Exspot typically last?

The product label states that protection against external parasites is maintained for up to four weeks. Retreatment frequency is based on these durations. Studies have monitored and tracked the duration of the effect typically up to 35 to 42 days post-treatment in controlled settings.


Q: Can Exspot interact with common supplements like vitamins?

The official interaction profile for the target species (dogs) does not contain documentation for classical systemic drug-drug interactions. The noted restrictions are confined to avoiding concurrent use with other topical parasiticides to prevent potential additive toxicity.


Q: Is it normal to feel a bit dizzy after the first use of Exspot?

Exspot is for veterinary use in dogs only. In dogs, neurological signs such as muscle tremor, twitching, or ataxia (unsteady movement or imbalance) are officially listed as a rare to very rare adverse reaction. Adverse effects that occur are generally noted as transient, meaning they resolve on their own.


Q: Can Exspot be used if someone has liver problems?

Exspot is for use in dogs only. Official contraindications advise against use in dogs that are sick or convalescent. While specific organ problems like liver issues are not named, this general restriction indicates that any use should be evaluated by a licensed veterinarian.


Q: What information is available about Exspot and pregnancy or breastfeeding?

Safety for use during pregnancy, lactation, or in breeding animals has not been established in regulatory documents. For these situations, the medicine should only be used after a formal benefit-risk assessment has been carried out by a licensed veterinarian.


Q: Does Exspot affect the ability to concentrate?

Exspot is for use in dogs only. Behavioral changes such as agitation or hyperactivity are officially listed as a rare to very rare adverse reaction in dogs. This indicates potential effects on the animal's alertness or focus, which are usually transient.


Q: Does Exspot have a risk of addiction?

Exspot is an ectoparasiticide solution containing Permethrin, classified as an insecticide. Regulatory documents focus on toxicity and species constraints. There is no information regarding dependence or addiction risk in the target species.


Q: What age group is Exspot typically used for?

The product is officially authorized for use in puppies 2 weeks old or older, provided they meet the minimum weight requirements (which can vary). The medicine is otherwise intended for use in adult dogs, as safety has not been established for very low-weight dogs.


Q: Are there any known skin reactions associated with Exspot?

Yes, officially documented adverse effects are primarily related to the application site. These are classified as Very Rare and include transient signs such as erythema (redness), pruritus (itching), or discomfort where the solution was applied. Localized effects typically resolve spontaneously within 24 hours.


Q: Does the time of day matter when using Exspot?

The directions for use note that treatment may be performed in the evening. A critical safety precaution is that the treated dog must not be allowed to sleep with people, especially children, immediately following the application.


Q: What kind of research has been done on the long-term use of Exspot?

The evidence base focuses mainly on intermediate duration follow-up periods, monitoring effects typically up to three to six weeks in controlled settings. Regulatory documents explicitly state that the long-term effects of this product are not fully established.

How should Exspot be stored and disposed of?

How to Store and Dispose of Exspot

The storage and disposal of Exspot must strictly adhere to the conditions outlined in the official regulatory labeling to maintain product stability and ensure household safety.


Required Storage Conditions

Exspot must be kept at room temperature, specifically below 25 C (77 F), and must be protected from freezing. The product should remain in its original container until the time of use. For safety, it must be stored out of the sight and reach of children and pets.


Official Disposal Instructions

To dispose of unused product, expired doses, or empty containers, the item must be wrapped and placed in the trash. The labeling explicitly requires taking precautions to prevent the contamination of water, food, or feed during both the storage and disposal processes.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Exspot found in:

A-Z Index: